As GLP-1 drugs go mainstream, this expert says health is more than a number on a scale

Popular weight-loss drugs known as GLP-1s could soon become more affordable for Americans. On Thursday, the Trump administration and two major drugmakers announced an agreement to drastically reduce the cost of the drugs for people enrolled in Medicare and Medicaid, as well as for cash buyers.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup